What changed: Gastrointestinal stromal tumour (GIST)
Every dated change on the records linked to Gastrointestinal stromal tumour (GIST), newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.
Approval5Regulatory2Milestone9This record1
September 2026 · 1
2022 · 1
2020 · 3
- 2020ApprovalAvapritinibAvapritinib approved in US
Unresectable/metastatic GIST with PDGFRA exon 18 mutation including D842V
- 2020ApprovalRipretinibRipretinib approved in US
Advanced GIST after ≥3 prior kinase inhibitors including imatinib
- 2020MilestoneAvapritinibAvapritinib (PDGFRA D842V) and ripretinib (INVICTUS) approved
A milestone in how this cancer is treated.